Augmenix

Augmenix

Augmenix

Augmenix is a medical device company that develops space-filling hydrogels forradiation oncology and cancer surgery indications.
Founded
2008
Raised
$25.9M
Follow us
Alexa global traffic share
Acquired by
Boston Scientific
1
08 Sep 2018
$600,000,000
Latest funding Show all
$6,000,000
Venture capital (Series E) - 2016
$10,800,000
Venture capital (Series D) - 2014
$600,000,000
FinSMEs

Boston Scientific To Acquire Augmenix, for $600M

Robotics Health Funding
VentureBeat

Augmenix to Present at the 36th Annual J.P. Morgan Healthcare Conference

$6,000,000 Venture capital (Series E)
MassDevice

Augmenix raises $6m in Series E round